Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Author index

Page Path
HOME > Browse articles > Author index
Search
Dai Ishikawa 1 Article
IBD
Successful remission of ulcerative colitis flare-up during pregnancy with adsorptive granulomonocytapheresis plus tacrolimus
Tomoyoshi Shibuya, Keiichi Haga, Masato Kamei, Koki Okahara, Shoko Ito, Masahito Takahashi, Osamu Nomura, Takashi Murakami, Masae Makino, Tomohiro Kodani, Dai Ishikawa, Naoto Sakamoto, Taro Osada, Tatsuo Ogihara, Sumio Watanabe, Akihito Nagahara
Intest Res 2018;16(3):484-488.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.484
AbstractAbstract PDFPubReaderePub

Ulcerative colitis (UC) is 1 of the 2 major phenotypes of chronic inflammatory bowel disease (IBD), which afflicts millions of individuals throughout the world with debilitating symptoms that impair function and quality of life. Further, IBD often affects women during childbearing age. Indeed, UC activity frequently increases during pregnancy, and the medications used to induce remission may adversely affect the health of the mother and the unborn child. We report successful induction of a remission in a UC case who experienced a flare-up in the first trimester of pregnancy. Upon relapse, she was treated with steroids and adsorptive granulomonocytapheresis (GMA) with the Adacolumn plus tacrolimus. This combination therapy induced a stable remission that was maintained during her entire pregnancy. She gave birth to a healthy child at 36 weeks of pregnancy with no maternal or fetal complications. Our experience indicates that GMA, as a non-drug therapeutic intervention with a favorable safety profile, plus tacrolimus might be a relevant treatment option for patients with active IBD during pregnancy. A future study of a large cohort of pregnant patients should strengthen our findings.

Citations

Citations to this article as recorded by  
  • Adsorptive cytapheresis in ulcerative colitis: A non‐pharmacological therapeutic approach revisited
    Filippo Vernia, Angelo Viscido, Giovanni Latella
    Journal of Clinical Apheresis.2023; 38(6): 746.     CrossRef
  • Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease
    Farah Yasmin, Hala Najeeb, Unaiza Naeem, Abdul Moeed, Thoyaja Koritala, Salim Surani
    World Journal of Clinical Cases.2022; 10(21): 7195.     CrossRef
  • Reproductive Health in IBD Patients
    Sanket Patel, Haleh Vaziri
    Current Treatment Options in Gastroenterology.2021; 19(2): 237.     CrossRef
  • Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future
    Xiu-Li Chen, Jing-Wei Mao, Ying-De Wang
    World Journal of Gastrointestinal Pathophysiology.2020; 11(3): 43.     CrossRef
  • Women’s Health and Ulcerative Colitis
    Kindra Clark-Snustad, Madalina Butnariu, Anita Afzali
    Gastroenterology Clinics of North America.2020; 49(4): 769.     CrossRef
  • 10,661 View
  • 111 Download
  • 3 Web of Science
  • 5 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP